Evolocumab: Uses, Dosage, Side Effects, Warnings - Drugs.com
2024年4月12日 · Evolocumab is an FDA approved medicine designed to treat high LDL (low-density lipoprotein) cholesterol levels. It is a monoclonal antibody that binds to PCSK9 protein which decreases LDL cholesterol levels.
Evolocumab - Wikipedia
Evolocumab, [6] sold under the brand name Repatha, is a monoclonal antibody that is an immunotherapy medication for the treatment of hyperlipidemia. Evolocumab is a fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9).
Evolocumab (subcutaneous route) - Mayo Clinic
2024年1月31日 · It is also used in patients with a heart and blood vessel disease to reduce the risk of heart attack, stroke, and certain types of heart surgery. This medicine is a PCSK9 (proprotein convertase subtilisin kexin type 9) inhibitor. This medicine is available only with your doctor's prescription.
Evolocumab and Clinical Outcomes in Patients with ...
2017年5月4日 · Evolocumab is a monoclonal antibody that inhibits proprotein convertase subtilisin–kexin type 9 (PCSK9) and lowers low-density lipoprotein (LDL) cholesterol levels by approximately 60%....
Repatha (evolocumab) dosing, indications, interactions ...
Adjunct to diet, alone or in combination with other lipid-lowering therapies (eg, statins), for treatment of primary hyperlipidemia, including heterozygous familial hyperlipidemia (HeFH), to reduce...
Repatha: Uses, Dosage & Side Effects - Drugs.com
Repatha (evolocumab) is a PCSK9 inhibitor used for hypercholesterolemia (high cholesterol) and cardiovascular risk reduction. Includes Repatha side effects, interactions and indications.
What is Repatha® (evolocumab)?
lower bad (LDL) cholesterol and reduce your risk of heart attack. This is Sam. He does not have high bad cholesterol. He also performs tasks perfectly. When trying to lower your cholesterol, you’re expected to be perfect —like Sam.